CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence

被引:193
作者
Yurchenko, Ekaterina
Tritt, Michael
Hay, Valerie
Shevach, Ethan M.
Belkaid, Yasmine
Piccirillo, Ciriaco A. [1 ]
机构
[1] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada
[2] McGill Univ, Strateg Training Ctr Infect Dis & Autoimmun, Montreal, PQ H3A 2B4, Canada
[3] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA
[4] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1084/jem.20060956
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pathogen persistence after clinical cure is a hallmark of many chronic infections. Previously, we showed that naturally occurring CD4(+)CD25(+) regulatory T (nTreg) cells rapidly accumulate within chronic dermal sites of Leishmania major infection where they suppress antipathogen CD4(+) T cell responses, favor parasite persistence and dermal pathology, and consequently control concomitant immunity. Here, we postulated that chemokines might direct nTreg cell homing in sites of infection and show that CD4(+)CD25(+) nTreg cells, compared with normal CD4(+) T cells, preferentially express the CCR5 chemokine receptor, which enables them to migrate in response to CCR5 ligands in vitro. We show that in contrast to their wild-type (WT) counterparts, CCR5(-/-) CD4(+)CD25(+) nTreg cells resulted in an increased magnitude of parasite-specific, interferon gamma-producing CD4(+) T cells within infection sites, dramatically reduced parasite numbers, and potent resistance to infection, a finding consistent with the clinical outcome of infected CCR5(-/-) mice. Interestingly, this resistance was related to an inefficient migration of CCR5(-/-) nTreg cells to infected dermal sites compared with WT nTreg cells. Thus, this study shows that CCR5 directs the homing of CD4(+) CD25(+) nTreg cells to L. major-infected dermal sites where they promote the establishment of infection and long-term survival of the parasite in the immune host.
引用
收藏
页码:2451 / 2460
页数:10
相关论文
共 48 条
[1]   Chemokine gene expression in toll-like receptor-competent and -deficient mice infected with Leishmania major [J].
Antoniazi, S ;
Price, HP ;
Kropf, P ;
Freudenberg, MA ;
Galanos, C ;
Smith, DF ;
Müller, I .
INFECTION AND IMMUNITY, 2004, 72 (09) :5168-5174
[2]   Natural regulatory T cells in infectious disease [J].
Belkaid, Y ;
Rouse, BT .
NATURE IMMUNOLOGY, 2005, 6 (04) :353-360
[3]   A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity [J].
Belkaid, Y ;
Mendez, S ;
Lira, R ;
Kadambi, N ;
Milon, G ;
Sacks, D .
JOURNAL OF IMMUNOLOGY, 2000, 165 (02) :969-977
[4]  
Belkaid Y, 2003, EXPERT OPIN BIOL TH, V3, P875, DOI 10.1517/14712598.3.6.875
[5]   CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major [J].
Belkaid, Y ;
Von Stebut, E ;
Mendez, S ;
Lira, R ;
Caler, E ;
Bertholet, S ;
Udey, MC ;
Sacks, D .
JOURNAL OF IMMUNOLOGY, 2002, 168 (08) :3992-4000
[6]   CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity [J].
Belkaid, Y ;
Piccirillo, CA ;
Mendez, S ;
Shevach, EM ;
Sacks, DL .
NATURE, 2002, 420 (6915) :502-507
[7]   The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure [J].
Belkaid, Y ;
Hoffmann, KF ;
Mendez, S ;
Kamhawi, S ;
Udey, MC ;
Wynn, TA ;
Sacks, DL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (10) :1497-1506
[8]   How do CD4+CD25+ regulatory T cells control autoimmunity? [J].
Bluestone, JA ;
Tang, QZ .
CURRENT OPINION IN IMMUNOLOGY, 2005, 17 (06) :638-642
[9]   B cells and professional APCs recruit regulatory T cells via CCL4 [J].
Bystry, RS ;
Aluvihare, V ;
Welch, KA ;
Kallikourdis, M ;
Betz, AG .
NATURE IMMUNOLOGY, 2001, 2 (12) :1126-1132
[10]   Mechanisms of disease - The many roles of chemokines and chemokine receptors in inflammation [J].
Charo, IF ;
Ransohoff, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :610-621